C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/12 (2006.01)
Patent
CA 2568331
Human PFK genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of PFK are provided.
L'invention concerne des gènes PFK humains identifiés comme modulateurs de la voie IGFR et, par conséquent, comme cibles thérapeutiques pour des troubles associés à une fonction IGFR défectueuse. L'invention concerne également des méthodes destinées à identifier des modulateurs d'IGFR et consistant à rechercher par criblage des agents modulant l'activité de PFK.
Bjerke Lynn Margaret
Francis-Lang Helen
Friedman Lori
Heuer Timothy S.
Parks Annette L.
Bennett Jones Llp
Bjerke Lynn Margaret
Exelixis Inc.
Francis-Lang Helen
Friedman Lori
LandOfFree
Pfks as modifiers of the igfr pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pfks as modifiers of the igfr pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pfks as modifiers of the igfr pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2007772